Vireo Growth Inc. Announces Second Quarter 2026 Results

Q2 GAAP revenue of $209.3 million increased 335% year-over-year, driven by recently closed M&A transactions. Q2 proforma revenue of $254.9 million, gives effect to the acquisitions of Hawthorne, Bridgewell, and PharmaCann as if they were completed on April 1, 2026. Assuming the completion of all announced acquisitions, Vireo will become the largest U.S. cannabis operator […]